DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
UNDERSTANDING DIABETES
Diabetes mellitus, often referred to simply as
DIABETES.
Diabetes is a condition in which the body:
• Does not produce enough insulin, and/or
• Does not properly respond to insulin
Insulin is a hormone produced in the pancreas. Insulin enables cells to
absorb glucose in order to turn it into energy.
3
Type 1 vs. Type 2
Type 1 diabetes Type 2 diabetes
Diagnosed in children
and young adults
Typically diagnosed in
adulthood
Previously known as
Juvenile Diabetes
Also found in overweight
children
Insulin-dependent Non-insulin-dependent
Body does not produce
insulin
Body fails to produce
and properly use insulin
DKA by Dr. A. Mandour.pptx
Blood Glucose Alterations
Complications of blood glucose alterations
• Hypoglycemia
• Hyperglycemia
• Ketosis
• Acidosis
• DKA (Hyperglycemia + Ketosis + Acidosis)
Normal fasting blood glucose level 4-6 mmol/L
DKA by Dr. A. Mandour.pptx
DIABETIC KETOACIDOSIS (DKA)
Hyperosmolar Hyperglycemic State (HHS)
DIABETIC KETOACIDOSIS (DKA)
• A state of absolute or relative insulin deficiency
aggravated by ensuing hyperglycemia, dehydration,
and acidosis-producing derangements in intermediary
metabolism, including production of serum acetone.
• Can occur in both Type I Diabetes and Type II
Diabetes
– In type II diabetics with insulin
deficiency/dependence
• The presenting symptom for ~ 25% of Type I
Diabetics.
DKA by Dr. A. Mandour.pptx
Diabetic KetoAcidosis (DKA)
1. 160,000 Admissions to private
hospitals/year
2. Cost = over 1 billion $ annually
3. 65% = <19 years old
4. Main cause of death in children with
diabetes (approximately 85%)
5. Cerebral edema in 69%
Hyperosmolar Hyperglycemic State (HHS)
• An acute metabolic complication of diabetes
mellitus characterized by impaired mental status
and elevated plasma osmolality in a patient with
hyperglycemia.
• Occurs predominately in Type II Diabetics
– A few reports of cases in type I diabetics.
• The presenting symptom for 30-40% of Type II
diabetics.
• Not commonly associated with ketonaemia and
acidosis
DKA by Dr. A. Mandour.pptx
The biochemical criteria for the diagnosis of DKA3,4
• Hyperglycemia - blood glucose greater than 11.1 mmol/L
• Ketosis - ketones present in blood and/or urine
• Acidosis - pH less than 7.3 and/or
bicarbonate less than 15 mmol/L
Classic Triad of DKA
DKA is generally categorized by the severity of the
acidosis.
• MILD – Venous pH less than 7.3 and/or
bicarbonate concentration less than 15 mmol/L
• MODERATE – Venous pH less than 7.2 and/or
bicarbonate concentration less than 10 mmol/L
• SEVERE – Venous pH less than 7.1 and/or
bicarbonate concentration less than 5 mmol/L
CLASSIFICATION OF DKA
DKA by Dr. A. Mandour.pptx
Risk factors for DKA at onset
• Age <12 yrs
• No first degree diabetic relative
• Lower socioeconomic status
• High dose glucocorticoids, atypical antipsychotics, diazoxide
and some immunosuppresive drugs
• Poor access to medical care
• Uninsured
• Usage of SGLT-2 inhibitor – euglycaemic DKA
SGLT2 inhibitors blunt insulin production in the face of stress
hormones leading to increased ketotic metabolism
DKA by Dr. A. Mandour.pptx
Why do ketones develop?
No carbohydrate intake
• fasting
• gastroenteritis
• Atkins diet, neonates fed high-fat milk
Prolonged exercise, pregnancy
Lack of insulin activity
• onset of diabetes (insufficient secretion)
• interruption of insulin delivery in established pt
Increase in insulin resistance
• infection, illness, surgery, stress
Alcohol, salicylate ingestion, inborn metabolic errors
Causes of DKA/HHS
• Stressful precipitating event that results in increased
catecholamines, cortisol, glucagon.
– Infection (pneumonia, UTI)
– Alcohol, drugs
– Stroke
– Myocardial Infarction
– Pancreatitis
– Trauma
– Medications (steroids, thiazide diuretics)
– Non-compliance with insulin
DKA by Dr. A. Mandour.pptx
PATHOPHYSIOLOGY OF DKA
Wolfsdorf J, Glaser N, Sperling MA; American Diabetes Association. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the
American Diabetes Association. Diabetes Care. 2006;29(5):1150-1159.Reprinted with permission from The American DiabetesAssociation.
PATHOPHYSIOLOGY OF DKA
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
DKA is a complex metabolic state of: hyperglycemia,
ketosis, and acidosis
Symptoms include:
– Deep, rapid breathing
– Fruity breath odor
– Very dry mouth
– Nausea and vomiting
– Lethargy/drowsiness
DKA is life-threatening and needs immediate treatment
Symptoms of DKA/HHS
• Polyuria
• Polydypsia
• Blurred vision
• Nausea/Vomiting
• Abdominal Pain
• Fatigue
• Confusion
• Obtundation
Physical Examination in DKA/HHS
• Hypotension, tachycardia
• Kussmaul breathing (deep, labored breaths)
• Fruity odor to breath (due to acetone)
• Dry mucus membranes
• Confusion
• Abdominal tenderness
DKA by Dr. A. Mandour.pptx
Diagnostic Criteria for DKA and HHS
Mild DKA Moderate DKA Severe DKA HHS
Plasma glucose
mmol/L
> 14 > 14 > 14 > 33.3
Arterial pH 7.25-7.30 7.00-7.24 < 7.00 > 7.30
Sodium Bicarbonate
(mEq/L)
15 – 18 10 - <15 < 10 > 15
Urine Ketones Positive Positive Positive Small
Serum Ketones Positive Positive Positive Small
Serum Osmolality
(mOsm/kg)
Variable Variable Variable > 320
Anion Gap > 10 > 12 > 12 variable
Mental Status Alert Alert/Drowsy Stupor/Coma Stupor/Coma
Serum ketones positive if > 1mg/dl or < 0.1 mmol/L
Anion gap Na + K – Cl – Hco3 target < 10
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
Identify and Treat the Precipitating
Factor
• Insulin omission – MOST COMMON CAUSE of DKA
• New diagnosis of diabetes
• Infection / Sepsis
• Myocardial infarction
– Small rise in troponin may occur without overt
ischemia
– ECG changes may reflect hyperkalemia
• Thyrotoxicosis
• Drugs
Treatment of DKA
• Once resolved
– Convert to home insulin
regimen
– Prevent recurrence
• Initial hospital
management
– Replace fluid and
electrolytes
– IV Insulin therapy
– Glucose administration
– Watch for complications
– Disconnect insulin pump
Treatment of DKA
Fluids and Electrolytes
• Fluid replacement
–Restores perfusion of the tissues
•Lowers counterregulatory hormones
•Increase insulin sensitivity
–Average fluid deficit 3-5 liters
Initial fluid resuscitation
• 15 to 20 mL/kg lean body weight per hour
• (approximately 1000 mL/hour in an average-sized
person) for the first couple of hours
• Maximum of <50 mL/kg in the first four hours
• 1-2 liters of normal saline over the first 2 hours
• Slower rates of 500cc/hr x 4 hrs or 250 cc/hr x 4
hours-When fluid overload is a concern
• If hypernatremia develops ½ NS can be used
Treatment of DKA
Fluids and Electrolytes
• Hyperkalemia initially present
– Resolves quickly with insulin drip
– Once urine output is present and K<5.0, add 20-40
meq KCL per liter.
• Phosphate deficit
– May want to use Kphos
• Bicarbonate not given unless pH <7 or
bicarbonate <5 mmol/L
Treatment of DKA
Insulin Therapy
• IV bolus of 0.1-0.2 units/kg (~ 10 units) regular
insulin
• Follow with hourly regular insulin infusion
• Glucose levels
– Decrease 4 to 5.5 mmol/L per hour
– Minimize rapid fluid shifts
Treatment of DKA
Glucose Administration
• Supplemental glucose
– Hypoglycemia occurs
• Insulin has restored glucose uptake
• Suppressed glucagon
– Prevents rapid decline in plasma osmolality
• Rapid decrease in insulin could lead to cerebral edema
• Glucose decreases before ketone levels decrease
• Start glucose when plasma glucose < 16.6
mmol/L
Insulin-Glucose Infusion for DKA
Blood glucose Insulin Infusion D5W Infusion
<70 0.5 units/hr 150 cc/hr
70-100 1.0 125
101-150 2.0 100
151-200 3.0 100
201-250 4.0 75
251-300 6.0 50
301-350 8.0 0
351-400 10.0 0
401-450 12.0 0
451-500 15.0 0
>500 20.0 0
Treatment of HHS
• Hydration!!!
– Even more important than in DKA
• Find underlying cause and treat!
• Insulin drip
– Should be started only once aggressive hydration has
taken place.
– Switch to subcutaneous regimen once glucose <
11mmol/L and patient eating.
• Serial Electrolytes
– Potassium replacement.
Pottasium Replacement
• If the initial K is below 3.3 mmol/L,
IV potassium chloride (KCl; 20 to 40
mmol/hour, before insulin therapy till raise
the serum potassium concentration into the
normal range of 4 to 5 mmol/L
• 3.3 to 5.3 given iv K with insulin infusion
• If above 5.3 not to given iv K till level less than
than
Resolution of ketoacidosis in DKA
• ●Normalization of the serum anion gap (less
than 12 mEq/L) and blood beta-
hydroxybutyrate levels
• ●Patients with HHS are mentally alert and the
effective plasma osmolality has fallen below
315 mOsmol/kg
• ●The patient is able to eat
Caveat
• Urinary ketones by the nitroprusside method can
be used for the initial diagnosis of ketoacidosis
• It should not be used for monitoring resolution of
DKA.
• Nitroprusside reacts mainly with acetoacetate, to
a much lesser degree with acetone (which is not
an acid), and not with beta-hydroxybutyrate.
• A positive nitroprusside test may persist for up to
36 hours after resolution of the ketoacidosis due
to a positive reaction with acetone, which is
slowly eliminated,
Once DKA Resolved
Treatment
• Most patients require 0.5-0.6 units/kg/day
• Pubertal or highly insulin resistant patients
– 0.8-1.0 units/kg/day
• Long acting insulin
– 1/2-2/3 daily requirement
– NPH, Lente, Ultralente or Lantus
• Short acting insulin
– 1/3-1/2 given at meals
– Regular, Humalog, Novolog
• Give insulin at least 2 hours prior to weaning insulin
infusion.
Copyrightsapply
DKA by Dr. A. Mandour.pptx
Complications of DKA
• Infection
– Precipitates DKA
– Fever
– Leukocytosis can be secondary
to acidosis
• Shock
– If not improving with fluids
r/o MI
• Vascular thrombosis
– Severe dehydration
– Cerebral vessels
– Occurs hours to days after DKA
• Pulmonary Edema
– Result of aggressive fluid
resuscitation
• Cerebral Edema
– First 24 hours
– Mental status changes
– Tx: Mannitol
– May require intubation with
hyperventilation
DKA by Dr. A. Mandour.pptx
Prevention of DKA / HHS
• Type 1 diabetes
– Education around sick day management
– Continuation of insulin even when not eating
– Frequent monitoring when ill
• Type 2 diabetes
– Education around sick day management
– Frequent monitoring when ill
Prevention of DKA
Sick Day Rules
• Never omit insulin
– Cut long acting in half
• Prevent dehydration
and hypoglycemia
• Monitor blood sugars
frequently
• Monitor for ketosis
• Provide supplemental
fast acting insulin
• Treat underlying
triggers
• Maintain contact with
medical team
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx
Conclusion
• Successful management
requires
– Judicious use of fluids
• Establish good perfusion
– Insulin drip
• Steady decline
• Complete resolution of ketosis
– Electrolyte replacement
– Frequent neurological evaluations
– High suspicion for complications
• Determine etiology to avoid
recurrent episodes
DKA by Dr. A. Mandour.pptx
DKA by Dr. A. Mandour.pptx

More Related Content

PPTX
Hyperosmolar hyperglycemic state
PPTX
DIABETIC KETOACIDOSIS (DKA)
PPTX
Diabetic ketoacidosis DKA
PPTX
Diabetes Mellitus (DM)
PDF
Diabetic Ketoacidosis
PPTX
Diabetes mellitus
PPTX
Brittle diabetes Current Approach
PPTX
Diabetic ketoacidosis/DKA
Hyperosmolar hyperglycemic state
DIABETIC KETOACIDOSIS (DKA)
Diabetic ketoacidosis DKA
Diabetes Mellitus (DM)
Diabetic Ketoacidosis
Diabetes mellitus
Brittle diabetes Current Approach
Diabetic ketoacidosis/DKA

What's hot (20)

PPT
Insulin therapy dr shahjadaselim
PPTX
Hypoglycemia by Dr Shubham Jain
PPT
Insulin regimens
PPTX
Management of diabetes mellitus
PDF
Complications of Diabetes Mellitus
PPTX
DIABETIC KETOACIDOSIS IN CHILDREN by Dr.Gobinda
PPTX
Diabetes
PPT
Diabetic+Nephropathy
PPT
Diabetes and its Complication
PDF
Acute Coronary Syndrome
PPTX
Hypoglycemia
PPTX
PPTX
Diabetic Ketoacidosis management update
PPTX
Diabetes diagnosis
PPTX
ALDOSTERONISM
PPTX
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
PPTX
Diabetes Mellitus and its types
PPTX
Complications of diabetes mellitus
PPTX
Management of diabetic ketoacidosis dka
Insulin therapy dr shahjadaselim
Hypoglycemia by Dr Shubham Jain
Insulin regimens
Management of diabetes mellitus
Complications of Diabetes Mellitus
DIABETIC KETOACIDOSIS IN CHILDREN by Dr.Gobinda
Diabetes
Diabetic+Nephropathy
Diabetes and its Complication
Acute Coronary Syndrome
Hypoglycemia
Diabetic Ketoacidosis management update
Diabetes diagnosis
ALDOSTERONISM
Acute hyperglycemic states (DKA, HHC) - Dr. Kasyapa
Diabetes Mellitus and its types
Complications of diabetes mellitus
Management of diabetic ketoacidosis dka
Ad

Similar to DKA by Dr. A. Mandour.pptx (20)

PDF
Slides presentation on Diabetic KetoAcidosis DKA
PPT
Acute Complication of DM by Dr Shahjada Selim
PPTX
Diabetic Ketoacidosis as a complication of Diabetes
PPT
Diabetic ketoacidosis lecture 1
PPTX
Metabolic emergencies of diabetis mellitus
PPTX
Dibetic Ketoacidosis in Children
PDF
diabetesketoacidosis about education pdf
PPTX
Diabetes ketoacidosis
PPTX
PPTX
Diabetic Ketoacidosis
PPTX
MANAGEMENT OF DKA.pptx
PDF
dka-170312043320.pdfgghhfhdjrifgrgvfhdjfh
PPTX
PPTX
Diabetic ketoacidosis by dr. noman
PPTX
Diabeticketoacidosis presentation 2024- 2
PPT
Approch to a patient with acut comlications of dm
PPTX
Hyperglycaemic emergencies in Diabetes mellitus
PPTX
DKA.pptx
PPT
Diabetic ketoacidosis dka- egh-nsg.forum-palestine.com
Slides presentation on Diabetic KetoAcidosis DKA
Acute Complication of DM by Dr Shahjada Selim
Diabetic Ketoacidosis as a complication of Diabetes
Diabetic ketoacidosis lecture 1
Metabolic emergencies of diabetis mellitus
Dibetic Ketoacidosis in Children
diabetesketoacidosis about education pdf
Diabetes ketoacidosis
Diabetic Ketoacidosis
MANAGEMENT OF DKA.pptx
dka-170312043320.pdfgghhfhdjrifgrgvfhdjfh
Diabetic ketoacidosis by dr. noman
Diabeticketoacidosis presentation 2024- 2
Approch to a patient with acut comlications of dm
Hyperglycaemic emergencies in Diabetes mellitus
DKA.pptx
Diabetic ketoacidosis dka- egh-nsg.forum-palestine.com
Ad

More from AhmedMandour37 (7)

PPTX
dkadrsyed2584-190602083813 (1).pptx
PPTX
ibd-191006070029 (1).pptx
PPTX
NASH risk factors and management.pptx
PPTX
AB policy.pptx
PPTX
null-5.pptx
PPT
bad news2022MILITARY (1).ppt
PPTX
Risk factors of diabetes.pptx
dkadrsyed2584-190602083813 (1).pptx
ibd-191006070029 (1).pptx
NASH risk factors and management.pptx
AB policy.pptx
null-5.pptx
bad news2022MILITARY (1).ppt
Risk factors of diabetes.pptx

Recently uploaded (20)

PPTX
Acute Abdomen and its management updates.pptx
PPTX
Peripheral Arterial Diseases PAD-WPS Office.pptx
PDF
Demography and community health for healthcare.pdf
PPTX
Diabetic Foot- Foot Ulcer Classification.pptx
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PPTX
ENT-DISORDERS ( ent for nursing ). (1).p
PDF
NCCN CANCER TESTICULAR 2024 ...............................
PPTX
Approach to Abdominal trauma Gemme(COMMENT).pptx
PPTX
FORENSIC MEDICINE and branches of forensic medicine.pptx
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
PDF
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
PPTX
Genetics and health: study of genes and their roles in inheritance
PPTX
A Detailed Physiology of Endocrine System.pptx
PDF
FMCG-October-2021........................
PPTX
presentation on causes and treatment of glomerular disorders
PPTX
Type 2 Diabetes Mellitus (T2DM) Part 3 v2.pptx
PPTX
Approch to weakness &paralysis pateint.pptx
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
PPTX
Biostatistics Lecture Notes_Dadason.pptx
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
Acute Abdomen and its management updates.pptx
Peripheral Arterial Diseases PAD-WPS Office.pptx
Demography and community health for healthcare.pdf
Diabetic Foot- Foot Ulcer Classification.pptx
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
ENT-DISORDERS ( ent for nursing ). (1).p
NCCN CANCER TESTICULAR 2024 ...............................
Approach to Abdominal trauma Gemme(COMMENT).pptx
FORENSIC MEDICINE and branches of forensic medicine.pptx
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
Genetics and health: study of genes and their roles in inheritance
A Detailed Physiology of Endocrine System.pptx
FMCG-October-2021........................
presentation on causes and treatment of glomerular disorders
Type 2 Diabetes Mellitus (T2DM) Part 3 v2.pptx
Approch to weakness &paralysis pateint.pptx
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
Biostatistics Lecture Notes_Dadason.pptx
Local Anesthesia Local Anesthesia Local Anesthesia

DKA by Dr. A. Mandour.pptx

  • 3. UNDERSTANDING DIABETES Diabetes mellitus, often referred to simply as DIABETES. Diabetes is a condition in which the body: • Does not produce enough insulin, and/or • Does not properly respond to insulin Insulin is a hormone produced in the pancreas. Insulin enables cells to absorb glucose in order to turn it into energy. 3
  • 4. Type 1 vs. Type 2 Type 1 diabetes Type 2 diabetes Diagnosed in children and young adults Typically diagnosed in adulthood Previously known as Juvenile Diabetes Also found in overweight children Insulin-dependent Non-insulin-dependent Body does not produce insulin Body fails to produce and properly use insulin
  • 6. Blood Glucose Alterations Complications of blood glucose alterations • Hypoglycemia • Hyperglycemia • Ketosis • Acidosis • DKA (Hyperglycemia + Ketosis + Acidosis) Normal fasting blood glucose level 4-6 mmol/L
  • 8. DIABETIC KETOACIDOSIS (DKA) Hyperosmolar Hyperglycemic State (HHS)
  • 9. DIABETIC KETOACIDOSIS (DKA) • A state of absolute or relative insulin deficiency aggravated by ensuing hyperglycemia, dehydration, and acidosis-producing derangements in intermediary metabolism, including production of serum acetone. • Can occur in both Type I Diabetes and Type II Diabetes – In type II diabetics with insulin deficiency/dependence • The presenting symptom for ~ 25% of Type I Diabetics.
  • 11. Diabetic KetoAcidosis (DKA) 1. 160,000 Admissions to private hospitals/year 2. Cost = over 1 billion $ annually 3. 65% = <19 years old 4. Main cause of death in children with diabetes (approximately 85%) 5. Cerebral edema in 69%
  • 12. Hyperosmolar Hyperglycemic State (HHS) • An acute metabolic complication of diabetes mellitus characterized by impaired mental status and elevated plasma osmolality in a patient with hyperglycemia. • Occurs predominately in Type II Diabetics – A few reports of cases in type I diabetics. • The presenting symptom for 30-40% of Type II diabetics. • Not commonly associated with ketonaemia and acidosis
  • 14. The biochemical criteria for the diagnosis of DKA3,4 • Hyperglycemia - blood glucose greater than 11.1 mmol/L • Ketosis - ketones present in blood and/or urine • Acidosis - pH less than 7.3 and/or bicarbonate less than 15 mmol/L Classic Triad of DKA
  • 15. DKA is generally categorized by the severity of the acidosis. • MILD – Venous pH less than 7.3 and/or bicarbonate concentration less than 15 mmol/L • MODERATE – Venous pH less than 7.2 and/or bicarbonate concentration less than 10 mmol/L • SEVERE – Venous pH less than 7.1 and/or bicarbonate concentration less than 5 mmol/L CLASSIFICATION OF DKA
  • 17. Risk factors for DKA at onset • Age <12 yrs • No first degree diabetic relative • Lower socioeconomic status • High dose glucocorticoids, atypical antipsychotics, diazoxide and some immunosuppresive drugs • Poor access to medical care • Uninsured • Usage of SGLT-2 inhibitor – euglycaemic DKA SGLT2 inhibitors blunt insulin production in the face of stress hormones leading to increased ketotic metabolism
  • 19. Why do ketones develop? No carbohydrate intake • fasting • gastroenteritis • Atkins diet, neonates fed high-fat milk Prolonged exercise, pregnancy Lack of insulin activity • onset of diabetes (insufficient secretion) • interruption of insulin delivery in established pt Increase in insulin resistance • infection, illness, surgery, stress Alcohol, salicylate ingestion, inborn metabolic errors
  • 20. Causes of DKA/HHS • Stressful precipitating event that results in increased catecholamines, cortisol, glucagon. – Infection (pneumonia, UTI) – Alcohol, drugs – Stroke – Myocardial Infarction – Pancreatitis – Trauma – Medications (steroids, thiazide diuretics) – Non-compliance with insulin
  • 22. PATHOPHYSIOLOGY OF DKA Wolfsdorf J, Glaser N, Sperling MA; American Diabetes Association. Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care. 2006;29(5):1150-1159.Reprinted with permission from The American DiabetesAssociation.
  • 26. DKA is a complex metabolic state of: hyperglycemia, ketosis, and acidosis Symptoms include: – Deep, rapid breathing – Fruity breath odor – Very dry mouth – Nausea and vomiting – Lethargy/drowsiness DKA is life-threatening and needs immediate treatment
  • 27. Symptoms of DKA/HHS • Polyuria • Polydypsia • Blurred vision • Nausea/Vomiting • Abdominal Pain • Fatigue • Confusion • Obtundation
  • 28. Physical Examination in DKA/HHS • Hypotension, tachycardia • Kussmaul breathing (deep, labored breaths) • Fruity odor to breath (due to acetone) • Dry mucus membranes • Confusion • Abdominal tenderness
  • 30. Diagnostic Criteria for DKA and HHS Mild DKA Moderate DKA Severe DKA HHS Plasma glucose mmol/L > 14 > 14 > 14 > 33.3 Arterial pH 7.25-7.30 7.00-7.24 < 7.00 > 7.30 Sodium Bicarbonate (mEq/L) 15 – 18 10 - <15 < 10 > 15 Urine Ketones Positive Positive Positive Small Serum Ketones Positive Positive Positive Small Serum Osmolality (mOsm/kg) Variable Variable Variable > 320 Anion Gap > 10 > 12 > 12 variable Mental Status Alert Alert/Drowsy Stupor/Coma Stupor/Coma Serum ketones positive if > 1mg/dl or < 0.1 mmol/L Anion gap Na + K – Cl – Hco3 target < 10
  • 33. Identify and Treat the Precipitating Factor • Insulin omission – MOST COMMON CAUSE of DKA • New diagnosis of diabetes • Infection / Sepsis • Myocardial infarction – Small rise in troponin may occur without overt ischemia – ECG changes may reflect hyperkalemia • Thyrotoxicosis • Drugs
  • 34. Treatment of DKA • Once resolved – Convert to home insulin regimen – Prevent recurrence • Initial hospital management – Replace fluid and electrolytes – IV Insulin therapy – Glucose administration – Watch for complications – Disconnect insulin pump
  • 35. Treatment of DKA Fluids and Electrolytes • Fluid replacement –Restores perfusion of the tissues •Lowers counterregulatory hormones •Increase insulin sensitivity –Average fluid deficit 3-5 liters
  • 36. Initial fluid resuscitation • 15 to 20 mL/kg lean body weight per hour • (approximately 1000 mL/hour in an average-sized person) for the first couple of hours • Maximum of <50 mL/kg in the first four hours • 1-2 liters of normal saline over the first 2 hours • Slower rates of 500cc/hr x 4 hrs or 250 cc/hr x 4 hours-When fluid overload is a concern • If hypernatremia develops ½ NS can be used
  • 37. Treatment of DKA Fluids and Electrolytes • Hyperkalemia initially present – Resolves quickly with insulin drip – Once urine output is present and K<5.0, add 20-40 meq KCL per liter. • Phosphate deficit – May want to use Kphos • Bicarbonate not given unless pH <7 or bicarbonate <5 mmol/L
  • 38. Treatment of DKA Insulin Therapy • IV bolus of 0.1-0.2 units/kg (~ 10 units) regular insulin • Follow with hourly regular insulin infusion • Glucose levels – Decrease 4 to 5.5 mmol/L per hour – Minimize rapid fluid shifts
  • 39. Treatment of DKA Glucose Administration • Supplemental glucose – Hypoglycemia occurs • Insulin has restored glucose uptake • Suppressed glucagon – Prevents rapid decline in plasma osmolality • Rapid decrease in insulin could lead to cerebral edema • Glucose decreases before ketone levels decrease • Start glucose when plasma glucose < 16.6 mmol/L
  • 40. Insulin-Glucose Infusion for DKA Blood glucose Insulin Infusion D5W Infusion <70 0.5 units/hr 150 cc/hr 70-100 1.0 125 101-150 2.0 100 151-200 3.0 100 201-250 4.0 75 251-300 6.0 50 301-350 8.0 0 351-400 10.0 0 401-450 12.0 0 451-500 15.0 0 >500 20.0 0
  • 41. Treatment of HHS • Hydration!!! – Even more important than in DKA • Find underlying cause and treat! • Insulin drip – Should be started only once aggressive hydration has taken place. – Switch to subcutaneous regimen once glucose < 11mmol/L and patient eating. • Serial Electrolytes – Potassium replacement.
  • 42. Pottasium Replacement • If the initial K is below 3.3 mmol/L, IV potassium chloride (KCl; 20 to 40 mmol/hour, before insulin therapy till raise the serum potassium concentration into the normal range of 4 to 5 mmol/L • 3.3 to 5.3 given iv K with insulin infusion • If above 5.3 not to given iv K till level less than than
  • 43. Resolution of ketoacidosis in DKA • ●Normalization of the serum anion gap (less than 12 mEq/L) and blood beta- hydroxybutyrate levels • ●Patients with HHS are mentally alert and the effective plasma osmolality has fallen below 315 mOsmol/kg • ●The patient is able to eat
  • 44. Caveat • Urinary ketones by the nitroprusside method can be used for the initial diagnosis of ketoacidosis • It should not be used for monitoring resolution of DKA. • Nitroprusside reacts mainly with acetoacetate, to a much lesser degree with acetone (which is not an acid), and not with beta-hydroxybutyrate. • A positive nitroprusside test may persist for up to 36 hours after resolution of the ketoacidosis due to a positive reaction with acetone, which is slowly eliminated,
  • 45. Once DKA Resolved Treatment • Most patients require 0.5-0.6 units/kg/day • Pubertal or highly insulin resistant patients – 0.8-1.0 units/kg/day • Long acting insulin – 1/2-2/3 daily requirement – NPH, Lente, Ultralente or Lantus • Short acting insulin – 1/3-1/2 given at meals – Regular, Humalog, Novolog • Give insulin at least 2 hours prior to weaning insulin infusion.
  • 48. Complications of DKA • Infection – Precipitates DKA – Fever – Leukocytosis can be secondary to acidosis • Shock – If not improving with fluids r/o MI • Vascular thrombosis – Severe dehydration – Cerebral vessels – Occurs hours to days after DKA • Pulmonary Edema – Result of aggressive fluid resuscitation • Cerebral Edema – First 24 hours – Mental status changes – Tx: Mannitol – May require intubation with hyperventilation
  • 50. Prevention of DKA / HHS • Type 1 diabetes – Education around sick day management – Continuation of insulin even when not eating – Frequent monitoring when ill • Type 2 diabetes – Education around sick day management – Frequent monitoring when ill
  • 51. Prevention of DKA Sick Day Rules • Never omit insulin – Cut long acting in half • Prevent dehydration and hypoglycemia • Monitor blood sugars frequently • Monitor for ketosis • Provide supplemental fast acting insulin • Treat underlying triggers • Maintain contact with medical team
  • 54. Conclusion • Successful management requires – Judicious use of fluids • Establish good perfusion – Insulin drip • Steady decline • Complete resolution of ketosis – Electrolyte replacement – Frequent neurological evaluations – High suspicion for complications • Determine etiology to avoid recurrent episodes